Skip to Content
Merck
CN
  • Flavonolignans inhibit ADP induced blood platelets activation and aggregation in whole blood.

Flavonolignans inhibit ADP induced blood platelets activation and aggregation in whole blood.

International journal of biological macromolecules (2016-12-08)
Michal Bijak, Rafal Szelenberger, Joanna Saluk, Pawel Nowak
ABSTRACT

Flavonolignans are a group of active chemical compounds presented in the silymarin - a standardized extract obtained from fruits and seeds of Milk thistle (Silybum marianum L. Gaernt.). Since the 70s of the last century, flavonolignans have been regarded to the official medicine as a substances having hepatoprotective properties. However many researches performed in recent years have demonstrated that flavonolignans posses many other healthy properties including modulation of variety cell-signaling pathways. The aim of our study was to examine the effects of three major flavonolignans (silybin, silychristin and silydianin) on ADP-induced blood platelet activation using the flow cytometry analysis as well as determine the mechanism of this interaction by bioinformatic ligand docking method. We observed that all tested flavonolignans in dose-dependent manner inhibit formation of blood platelet aggregates and microparticles as well as decrease expression of P-selectin and activation of integrin α

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
PAC-1, ≥98% (HPLC)